Risk of Infectious Spondylitis After Tirzepatide Versus Semaglutide Initiation in Adults With Type 2 Diabetes: A Multinational Real-World Active-Comparator Cohort Study
Journal of Infection and Public Health · 2026-11 · 103424
DOI: 10.1016/j.jiph.2026.103424 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Infection and Public Health, 2026-11. Verfasst von Hao-En Jan und 5 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cheng Kung University Hospital.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Cheng Kung University Hospital
Zitieren
APA
Jan, H., Wang, J., Lee, C., Huang, T., Wu, M., & Tsai, S. H. L. (2026). Risk of Infectious Spondylitis After Tirzepatide Versus Semaglutide Initiation in Adults With Type 2 Diabetes: A Multinational Real-World Active-Comparator Cohort Study. Journal of Infection and Public Health, 103424. https://doi.org/10.1016/j.jiph.2026.103424
Vancouver
Jan H, Wang J, Lee C, Huang T, Wu M, Tsai SHL. Risk of Infectious Spondylitis After Tirzepatide Versus Semaglutide Initiation in Adults With Type 2 Diabetes: A Multinational Real-World Active-Comparator Cohort Study. Journal of Infection and Public Health. 2026:103424. doi:10.1016/j.jiph.2026.103424
BibTeX
@article{Jan2026,
author = {Jan, Hao-En and Wang, Jiun-Ling and Lee, Ching-Yu and Huang, Tsung-Jen and Wu, Meng-Huang and Tsai, Sung Huang Laurent},
title = {Risk of Infectious Spondylitis After Tirzepatide Versus Semaglutide Initiation in Adults With Type 2 Diabetes: A Multinational Real-World Active-Comparator Cohort Study},
journal = {Journal of Infection and Public Health},
year = {2026},
pages = {103424},
doi = {10.1016/j.jiph.2026.103424}
}
EUVIMED